Search
for
Sort by
Research 31–60 of 1000+
- Management of Mineral Supplementation Programs for Cow-Calf Operations
- Effect of a medicinal and edible decoction YH0618 on chemotherapy-induced dermatologic toxicity: a randomized controlled trial
- Skin Toxicity in Palliative Radiation Therapy
- IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes
- Hair eruption initiates and commensal skin microbiota aggravate adverse events of anti-EGFR therapy
- Cutaneous Toxicities of MEK Inhibitor Use in Children: A Comparison of Binimetinib and Selumetinib
- MARIO LACOUTURE: How Do I Treat a Patient with Dermatologic Toxicities to EGFR Inhibitors?
- Skin toxicity of anti‐cancer therapy
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Chronic Toxicity Studies of the Potential Cancer Preventive 2-(Difluoromethyl)-<i>dl</i>-ornithine
- 307 Dermatologic toxicities associated with chronic gamma-secretase inhibitor treatment for desmoid tumor
- Recent advances in the epidermal growth factor receptor/ligand system biology on skin homeostasis and keratinocyte stem cell regulation
- Classification and management of skin, hair, nail and mucosal side-effects of epidermal growth factor receptor (EGFR) inhibitors
- Clinical development and management of adverse events associated with FGFR inhibitors
- Chemotherapy-related adverse effects with anthracycline and taxane-containing regimens in patients with localized Breast cancer: a descriptive study
- Scalp-sparing total skin electron therapy in mycosis fungoides: Case report highlighting technique and outcome
- Management of Toxicities of Targeted Therapies
- Nonmelanoma skin cancer treated with electronic brachytherapy: Results at 1 year
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Risks of Skin, Hair, and Nail Supplements
- Scalp Pustule as a Manifestation of Erlotinib-Induced Skin Toxicity: Report of Two Cases and Literature Review
- Finasteride
- Cutaneous adverse effects of targeted therapies
- Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- Acute and Long-term Toxicity of Cyclophosphamide
- First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Cutaneous Adverse Events of Targeted Anticancer Therapy: A Review of Common Clinical Manifestations and Management